| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/10/2001 | US6214992 Use of theophylline derivatives for the treatment and prophylaxis of states of shock, novel xanthine compounds and processes for their preparation |
| 04/10/2001 | US6214887 For preventing or treating hyperproliferative vascular disease |
| 04/10/2001 | US6214880 Lowering plasma cholesterol levels and inhibiting abnormal cell proliferation with said compound; treatment of cancer, psoriasis, vascular restenosis, infections, atherosclerosis and hypercholesterolemia |
| 04/10/2001 | US6214876 Indene-1-acetamide sPLA2 inhibitors |
| 04/10/2001 | US6214870 Antiarthritic agents; anticancer agents |
| 04/10/2001 | US6214868 Side effect reduction, effectiveness |
| 04/10/2001 | US6214858 Caspases and apoptosis |
| 04/10/2001 | US6214856 Treating neurodegenerative disorders, e.g., alzheimer's disease, strokes, traumatic brain injury; antiischemic agents; muscular dystrophy; also cataracts; platelet aggregation |
| 04/10/2001 | US6214854 Administering adrenoceptor, or antagonist thereof; cardiovascular disorders |
| 04/10/2001 | US6214844 Substituted imidazole compounds |
| 04/10/2001 | US6214841 Anticoagulants |
| 04/10/2001 | US6214839 Substituted 6-alkylphenanthridines |
| 04/10/2001 | US6214817 Nitrogen macrocycle complexes with manganese and iron |
| 04/10/2001 | US6214810 Methods of treating or preventing cardiac arrhythmia |
| 04/10/2001 | US6214809 Methods of treating or preventing cardiac arrhythmia |
| 04/10/2001 | US6214807 Images and cardiovascular disorders |
| 04/10/2001 | US6214795 Polypetides with amino acid sequences |
| 04/10/2001 | US6214614 Cell cycle regulated repressor and DNA element |
| 04/10/2001 | US6214379 Useful for adaptation to schedules, cycles and needs of individuals improving compliance with their therapy, reducing amounts required daily to less than conventionally utilized, and minimizing undesired effects; drug delivery |
| 04/10/2001 | US6214336 Reducing the fibrinogen level and cholesterol level in blood |
| 04/10/2001 | US6214333 Vasoprotective recombinant adenovirus vector containing a human TFPI gene |
| 04/10/2001 | US6214318 Comprising mineral oils, vegetable oils, silicone oils or synthetic oils; thickening agents such as waxes to thicken oils to non-flowable state; optionally adjuvants, drugs and emulsifiers and a liquefied propellant; cooling effect |
| 04/10/2001 | CA2191858C Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy |
| 04/10/2001 | CA2162106C 5-(aryloxymethyl)oxazolines, process for preparing the same and pharmaceutical compositions containing them |
| 04/10/2001 | CA2140543C Thrombin receptor antagonists |
| 04/10/2001 | CA2133413C Indole derivatives as 5-ht1 antagonists |
| 04/10/2001 | CA2119661C New n-benzylpiperazine compounds, their preparation process and pharmaceutical compositions containing them |
| 04/10/2001 | CA2117532C Method of inhibiting carcinogenesis by treatment with dehydropiandrosterone and analogs thereof |
| 04/10/2001 | CA2086974C R(+)-terazosin |
| 04/05/2001 | WO2001023598A1 41 human secreted proteins |
| 04/05/2001 | WO2001023572A2 Polynucleotides and polypeptides encoded thereby |
| 04/05/2001 | WO2001023563A2 Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptors |
| 04/05/2001 | WO2001023554A1 The prv-1 gene and use thereof |
| 04/05/2001 | WO2001023547A1 26 human secreted proteins |
| 04/05/2001 | WO2001023546A1 37 human secreted proteins |
| 04/05/2001 | WO2001023408A1 5-hydroxysapogenin derivatives with anti-dementia activity |
| 04/05/2001 | WO2001023406A1 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia |
| 04/05/2001 | WO2001023402A1 43 human secreted proteins |
| 04/05/2001 | WO2001023399A1 Compounds for the treatment of ischemia |
| 04/05/2001 | WO2001023391A1 Triazolopurine derivatives, drug compositions containing the same and adenosine a3 receptor affinitive agents |
| 04/05/2001 | WO2001023390A2 Azepinoindole derivatives, the production and use thereof |
| 04/05/2001 | WO2001023389A2 Certain alkylene diamine-substituted heterocycles |
| 04/05/2001 | WO2001023388A2 AMINO SUBSTITUTED PYRAZOLO[1,5,-a]-1,5-PYRIMIDINES AND PYRAZOLO[1,5-a]-1,3,5-TRIAZINES |
| 04/05/2001 | WO2001023387A2 CERTAIN ALKYLENE DIAMINE-SUBSTITUTED PYRAZOLO[1,5,-a]-1,5-PYRIMIDINES AND PYRAZOLO[1,5-a]-1,3,5-TRIAZINES |
| 04/05/2001 | WO2001023386A2 Benzodiazepin derivatives, the production and use thereof |
| 04/05/2001 | WO2001023383A1 Quinuclidine compounds and drugs containing the same as the active ingredient |
| 04/05/2001 | WO2001023382A1 Pharmaceutically active sulfonyl hydrazide derivatives |
| 04/05/2001 | WO2001023381A1 Piperidine derivatives as reuptake inhibitors |
| 04/05/2001 | WO2001023379A1 Pharmaceutically active sulfonyl amino acid derivatives |
| 04/05/2001 | WO2001023378A1 Pharmaceutically active sulfonamide derivatives |
| 04/05/2001 | WO2001023377A2 Polymorphic salt |
| 04/05/2001 | WO2001023375A2 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 04/05/2001 | WO2001023364A1 Quinazolinones |
| 04/05/2001 | WO2001023361A1 Pyrimidine derivatives, process for preparing the derivatives and drugs containing the same as the active ingredient |
| 04/05/2001 | WO2001023360A1 Aryl sulfonamide-substituted benzimidazol derivatives thereof as tryptase inhibitors |
| 04/05/2001 | WO2001023359A1 Aryl-sulfonamide substituted benzimidazol derivatives and use of said as tryptase inhibitors |
| 04/05/2001 | WO2001023357A2 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists |
| 04/05/2001 | WO2001023349A1 Acylsulfonamide derivatives |
| 04/05/2001 | WO2001023347A1 Novel aromatic compounds |
| 04/05/2001 | WO2001023000A1 Coating preparations soluble in lower digestive tract |
| 04/05/2001 | WO2001022976A2 Combination of a statin and ex-vivo treated blood for treating artheroclerosis |
| 04/05/2001 | WO2001022959A2 Compositions comprising progesterone or progesterone analogs for the treatment of inflammatory conditions |
| 04/05/2001 | WO2001022949A2 Use of alprostadil (prostaglandin e1) for producing a medicament for angioneogenesis |
| 04/05/2001 | WO2001022940A1 Sustained release matrix systems for highly soluble drugs |
| 04/05/2001 | WO2001022937A1 Compositions of tocol-soluble therapeutics |
| 04/05/2001 | WO2001022921A2 Prevention of atherosclerosis and undesired blood clotting by reducing von willebrand factor |
| 04/05/2001 | WO2001012602A8 Condensed indoline derivatives and their use as 5ht, in particular 5ht2c, receptor ligands |
| 04/05/2001 | WO2001006015A8 NOVEL GLYCOSYL SULFOTRANSFERASES GST-4α, GST-4β, AND GST-6 |
| 04/05/2001 | WO2001002397A9 Tricyclic compounds having spiro union |
| 04/05/2001 | WO2000073450A3 Cytoskeleton-associated proteins |
| 04/05/2001 | WO2000072023A3 Diagnosis and treatment of atherosclerosis and coronary heart disease |
| 04/05/2001 | WO2000068198A3 Heterosubstituted pyridine derivatives as pde 4 inhibitors |
| 04/05/2001 | WO2000064474A8 Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
| 04/05/2001 | WO2000060051A8 Arpe-19 as a platform cell line for encapsulated cell-based delivery |
| 04/05/2001 | WO2000057877A8 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof |
| 04/05/2001 | WO2000057863A3 Use of pyridoxine compounds for treatment of cardiovascular and related pathologies |
| 04/05/2001 | WO2000056891A3 Human transmembrane proteins |
| 04/05/2001 | WO2000051547A3 Inhibitors of prenyl-protein transferase |
| 04/05/2001 | WO2000047197A3 Alkylating agents for treatment of cellular proliferation |
| 04/05/2001 | WO2000044362A3 The use of 4-h-1-benzopyran-4-one derivatives as inhibitors of smooth muscle cell proliferation |
| 04/05/2001 | WO2000030668A9 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration |
| 04/05/2001 | WO1996018391B1 Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor |
| 04/05/2001 | US20010000143 Using dimethyl ether and elevated temperature/pressure to dissolve the solid; releasing the pressure to precipitate the fine powder and expand the ether into a gas; drugs; vitamins; carotenoid, especially beta-carotene; foods; cosmetics |
| 04/05/2001 | DE19947457A1 New 2'-aminomethyl-biphenyl-2-carboxamide derivatives, are potassium channel blockers especially useful for treating re-entry or supraventricular arrhythmia or atrial fibrillation or flutter |
| 04/05/2001 | DE19947010A1 Das Gen PRV-1 und dessen Verwendung The PRV-1 gene and its use |
| 04/05/2001 | CA2657208A1 Method of treating inflammatory conditions with progesterone of progesterone analogs |
| 04/05/2001 | CA2640998A1 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia |
| 04/05/2001 | CA2387702A1 The prv-1 gene and use thereof |
| 04/05/2001 | CA2386346A1 Novel polynucleotides and polypeptides encoded thereby |
| 04/05/2001 | CA2386092A1 Piperidine derivatives |
| 04/05/2001 | CA2386079A1 Compounds for the treatment of ischemia |
| 04/05/2001 | CA2385989A1 Compositions of tocol-soluble therapeutics |
| 04/05/2001 | CA2385918A1 Quinazolinones |
| 04/05/2001 | CA2385887A1 Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptors |
| 04/05/2001 | CA2385884A1 26 human secreted proteins |
| 04/05/2001 | CA2385865A1 Triazolopurine derivatives, pharmaceutical compositions containing the derivatives, and adenosine a3 receptor affinitive agents |
| 04/05/2001 | CA2385292A1 Pyrimidine compounds, processes for the preparation thereof and pharmaceutical compositions comprising the compounds as active ingredient |
| 04/05/2001 | CA2385169A1 43 human secreted proteins |
| 04/05/2001 | CA2385001A1 Pharmaceutically active sulfonyl hydrazide derivatives |
| 04/05/2001 | CA2384997A1 Pharmaceutically active sulfonyl amino acid derivatives |